These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 11768586

  • 1. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
    Voznyi YV, Keulemans JL, van Diggelen OP.
    J Inherit Metab Dis; 2001 Nov; 24(6):675-80. PubMed ID: 11768586
    [Abstract] [Full Text] [Related]

  • 2. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type II (Hunter syndrome)].
    Zhang WM, Shi HP, Li BT, Zhao SM, Qi QW, Sun NH, Huang SZ.
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):644-7. PubMed ID: 17217652
    [Abstract] [Full Text] [Related]

  • 3. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type D (MPS IIID).
    He W, Voznyi YaV, Boer AM, Kleijer WJ, van Diggelen OP.
    J Inherit Metab Dis; 1993 Sep; 16(6):935-41. PubMed ID: 8127069
    [Abstract] [Full Text] [Related]

  • 4. Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples.
    Dean CJ, Bockmann MR, Hopwood JJ, Brooks DA, Meikle PJ.
    Clin Chem; 2006 Apr; 52(4):643-9. PubMed ID: 16497940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.
    Lee K, Jun SH, Song SH, Park HD, Park KU, Song J.
    Clin Biochem; 2015 Dec; 48(18):1350-3. PubMed ID: 26297117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots.
    Tolun AA, Graham C, Shi Q, Sista RS, Wang T, Eckhardt AE, Pamula VK, Millington DS, Bali DS.
    Mol Genet Metab; 2012 Mar; 105(3):519-21. PubMed ID: 22227323
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluorometric measurement of alpha-L-iduronidase activity using 4-methylumbelliferyl-alpha-L-iduronide.
    Minami R, Watanabe Y, Kudoh T, Oyanagi K, Nakao T.
    Tohoku J Exp Med; 1980 Apr; 130(4):381-4. PubMed ID: 6781103
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A method for measuring disease-specific iduronic acid from the non-reducing end of glycosaminoglycan in mucopolysaccharidosis type II mice.
    Shimada Y, Wakabayashi T, Akiyama K, Hoshina H, Higuchi T, Kobayashi H, Eto Y, Ida H, Ohashi T.
    Mol Genet Metab; 2016 Feb; 117(2):140-3. PubMed ID: 26051019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.